DE3854684D1 - Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate. - Google Patents

Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate.

Info

Publication number
DE3854684D1
DE3854684D1 DE3854684T DE3854684T DE3854684D1 DE 3854684 D1 DE3854684 D1 DE 3854684D1 DE 3854684 T DE3854684 T DE 3854684T DE 3854684 T DE3854684 T DE 3854684T DE 3854684 D1 DE3854684 D1 DE 3854684D1
Authority
DE
Germany
Prior art keywords
processes
preparation
pharmaceutical preparations
substituted
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3854684T
Other languages
English (en)
Other versions
DE3854684T2 (de
Inventor
Jean Claude Arnould
Thomas Geoffrey Colerick Bird
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Original Assignee
Zeneca Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Pharma SA filed Critical Zeneca Pharma SA
Application granted granted Critical
Publication of DE3854684D1 publication Critical patent/DE3854684D1/de
Publication of DE3854684T2 publication Critical patent/DE3854684T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3854684T 1987-07-23 1988-07-12 Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate. Expired - Fee Related DE3854684T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401720 1987-07-23

Publications (2)

Publication Number Publication Date
DE3854684D1 true DE3854684D1 (de) 1995-12-21
DE3854684T2 DE3854684T2 (de) 1996-03-28

Family

ID=8198239

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3854684T Expired - Fee Related DE3854684T2 (de) 1987-07-23 1988-07-12 Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate.

Country Status (5)

Country Link
US (1) US5013730A (de)
EP (1) EP0304155B1 (de)
JP (1) JPS6440488A (de)
AT (1) ATE130299T1 (de)
DE (1) DE3854684T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8811056D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
US5149803A (en) * 1988-05-10 1992-09-22 Imperial Chemical Industries Plc Intermediates for cephalosporin compounds
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
EP0997466A1 (de) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Antimikrobielle Laktamchinolone
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
JPH05506033A (ja) * 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 抗微生物性キノロニルラクタム類
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
WO2002053162A1 (en) * 2000-12-29 2002-07-11 Alteon, Inc. Method for treating glaucoma iiib
AR088218A1 (es) 2011-07-19 2014-05-21 Infinity Pharmaceuticals Inc Compuestos heterociclicos utiles como inhibidores de pi3k

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
GB8413152D0 (en) * 1983-06-03 1984-06-27 Ici Pharma Cephalosporin derivatives
DE3581891D1 (de) * 1984-11-12 1991-04-04 Banyu Pharma Co Ltd Cephalosporinderivate.
EP0182633A3 (de) * 1984-11-20 1987-09-02 Ici Pharma Cephalosporinderivate
ES8704943A1 (es) * 1984-12-27 1987-04-16 Banyu Pharma Co Ltd Un procedimiento para la fabricacion de derivados de cefalosporina.
CA1296012C (en) * 1986-03-19 1992-02-18 Susumu Nakagawa 6,7-dihydroxy-isoquinoline derivatives
DE3750411T2 (de) * 1986-04-14 1995-03-16 Banyu Pharma Co Ltd Cephalosporinderivate, Verfahren zu ihrer Herstellung und antibakterielle Präparate.
EP0272827A3 (de) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-Heterocyclethiomethyl-cephalosporine

Also Published As

Publication number Publication date
JPS6440488A (en) 1989-02-10
EP0304155A3 (en) 1990-10-31
EP0304155B1 (de) 1995-11-15
DE3854684T2 (de) 1996-03-28
ATE130299T1 (de) 1995-12-15
US5013730A (en) 1991-05-07
EP0304155A2 (de) 1989-02-22

Similar Documents

Publication Publication Date Title
DE3850321D1 (de) Cephalosporine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate.
DE3854684D1 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate.
DE69032681D1 (de) Cephalosporine und ihre Homologen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
DE3788306D1 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung sowie entsprechende pharmazeutische Präparate.
EP0267733A3 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE68919273D1 (de) Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
DE69027718D1 (de) Cephalosporine, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Präparate und ihre Zwischenverbindungen
AU554959B2 (en) Triazolo(4,3-a) quinazolin-5-ones
ATE11915T1 (de) Benzothiazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
DE68920474D1 (de) Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
EP0272827A3 (de) 3-Heterocyclethiomethyl-cephalosporine
DE3750673D1 (de) Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
ATE33392T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende antibiotische medikamente.
DE3161553D1 (en) Thiazolo(3,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
DE68919433D1 (de) Cephalosporine, Verfahren zu ihrer Herstellung, Zwischenverbindungen und pharmazeutische Präparate.
SE7905051L (sv) Nya sulfonamider
DE3854804D1 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE3171431D1 (en) Derivatives of 7-beta-(ketoximinoacylamido)-ceph-3-em-4-carboxylic acids, process for their preparation and their pharmaceutical compositions containing them
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
EP0300664A3 (de) Cephalosporinverbindungen
EP0042232A3 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee